Asset Management One Co. Ltd. Acquires 2,589 Shares of Teleflex Incorporated (NYSE:TFX)

Asset Management One Co. Ltd. lifted its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 15.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,233 shares of the medical technology company's stock after purchasing an additional 2,589 shares during the quarter. Asset Management One Co. Ltd.'s holdings in Teleflex were worth $3,453,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of TFX. Exchange Traded Concepts LLC purchased a new position in shares of Teleflex in the 3rd quarter worth about $61,000. Creative Planning increased its holdings in Teleflex by 7.8% in the 3rd quarter. Creative Planning now owns 5,671 shares of the medical technology company's stock worth $1,403,000 after buying an additional 412 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in Teleflex by 25.9% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 4,873 shares of the medical technology company's stock worth $1,205,000 after buying an additional 1,001 shares in the last quarter. Blue Trust Inc. increased its holdings in Teleflex by 47.2% in the 3rd quarter. Blue Trust Inc. now owns 312 shares of the medical technology company's stock worth $77,000 after buying an additional 100 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC increased its holdings in Teleflex by 41.5% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 24,301 shares of the medical technology company's stock worth $6,010,000 after buying an additional 7,132 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company's stock.

Teleflex Stock Performance

Shares of TFX stock traded up $0.30 during trading hours on Friday, reaching $175.43. 397,701 shares of the company traded hands, compared to its average volume of 491,425. Teleflex Incorporated has a 12-month low of $165.62 and a 12-month high of $249.90. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The company has a market cap of $8.15 billion, a P/E ratio of 34.88, a P/E/G ratio of 1.73 and a beta of 1.16. The firm has a 50-day moving average price of $177.07 and a 200 day moving average price of $207.80.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Needham & Company LLC reiterated a "hold" rating on shares of Teleflex in a report on Monday, December 16th. Truist Financial reduced their price objective on Teleflex from $227.00 to $200.00 and set a "hold" rating for the company in a report on Wednesday, December 18th. Royal Bank of Canada cut their price target on Teleflex from $275.00 to $245.00 and set an "outperform" rating for the company in a research note on Friday, November 1st. StockNews.com upgraded Teleflex from a "hold" rating to a "buy" rating in a research note on Thursday, November 28th. Finally, Mizuho cut their price target on Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a research note on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $252.50.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.